{"version":"1.0","provider_name":"Humanitas.net","provider_url":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/","author_name":"Emicha","author_url":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/author\/emicha\/","title":"\u00a0Everolimus - Humanitas.net","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"r0PP73HjqE\"><a href=\"https:\/\/humanitas-net.humweb.webiz.team\/sr\/wiki\/everolimus-2\/\">\u00a0Everolimus<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/humanitas-net.humweb.webiz.team\/sr\/wiki\/everolimus-2\/embed\/#?secret=r0PP73HjqE\" width=\"600\" height=\"338\" title=\"&#8220;\u00a0Everolimus&#8221; &#8212; Humanitas.net\" data-secret=\"r0PP73HjqE\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/humanitas-net.humweb.webiz.team\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"Everolimus se primenjuje u\u00a0 terapiji odre\u0111enih formi karcinoma dojki kod postmenopauzalnih osoba \u017eenskog pola kod kojih terapija drugim reagensima nije uspe\u0161na. Tako\u0111e se primenjuje kod odre\u0111enih formi neuroendokrinih tumora, uznapredovalih formi karcinoma bubrega rezistentnih na terapiju sorafenibom ili sunitibom, kao i odre\u0111ene forme renalnih angiomiolipoma, tuberozne forme skleroze, kao i astrocitoma subependimalnih gigantskih \u0107elija. &nbsp; [&hellip;]"}